Hello.
Manage your child's medical information and connect with your Arkansas Children's medical team online.
Login Sign upArkansas Children's Hospital
General Information 501-364-1100
Arkansas Children's Northwest
General Information 479-725-6800
A superiority study to compare the effect of Panzyga versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome.
The purpose of this study is to test the effectiveness of using an investigational agent called DFMO along with etoposide for Neuroblastoma. An investigational drug is one that has not been approved by the U.S. Food and Drug Administration (FDA).
Learn more about the HBCD Study, sponsored by the National Institutes of Health, the largest long-term study of early brain and child development in the United States.
We are studying how brain waves and structures in children relate to behavior, how you think and body weight, and how the brain's work changes under stress.